Image Quality Clinical Trial
Official title:
Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining
Verified date | January 2020 |
Source | Shandong University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study was to test an optimal concentration of Lugol's solution which can reduce the mucosal irritation and provide high image quality to ensure endoscopy examination by a randomized blinded controlled trial.
Status | Completed |
Enrollment | 200 |
Est. completion date | December 30, 2018 |
Est. primary completion date | November 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 74 Years |
Eligibility |
Inclusion Criteria: - patients in the high-risk population of ESCC; - or general risk population of ESCC between 40 to 74 years old. Definition of high-risk population of ESCC is list in supporting information33. Exclusion criteria included the following: - with obvious abnormalities in stomach, confirmed by either white-light endoscopy (WLE) or pCLE, including gastric cancer, acute erosive and hemorrhagic gastritis, chronic atrophic gastritis, H. pylori infection and severe bile reflux gastritis; - advanced esophageal carcinoma; - known esophageal surgery or endoscopic treatment; - known esophageal radiotherapy or chemotherapy; - esophageal stenosis; - food retention; - allergy to iodine or fluorescein sodium; - hyperthyroid; - coagulopathy; - acute bleeding; - severe organ failure; - pregnant or breastfeeding women. |
Country | Name | City | State |
---|---|---|---|
China | Qilu Hospital, Shandong University | Jinan | Shandong |
Lead Sponsor | Collaborator |
---|---|
Shandong University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Image Quality | Image quality is blindly quantified by a 4-point scale from the endoscopists. A higher score representing higher image quality. | intraoperative | |
Secondary | Gastric Mucosa Injury | The gastric mucosal injury caused by Lugol's solution is defined as post-staining gastritis score minus pre-staining gastritis score in pCLE. The confocal gastritis was graded 0 to 3,according to pit patterns, capillaries, and fluorescein leakage. A higher score representing more serious injury. | 1 months | |
Secondary | Adverse Events | Both a written and oral form of the Numerical Rating Scale (NRS) was provided to the patients after the endoscopy examination, used for measuring patients' retrosternal pain, retrosternal discomfort, nausea, abdominal discomfort and others. In NRS, 0 is painless, 10 is the most severe pain, less than 4 is mild pain (pain does not affect sleep), 4-6 is moderate pain, and more than 7 is severe pain (pain means unable to sleep or wake up from sleep). | 24 hours | |
Secondary | Severe Adverse Events | Severe adverse events includes allergic reactions, esophageal burns, spasms and even perforation. | 24 hours | |
Secondary | Tolerance | The 4-point scale was used to assess the tolerance of endoscopist to the esophageal spasm caused by Lugol's solution which prevent endoscopy from passing. 1-4 means the resistance as intolerable, tolerable, mild, or non-existing. | intraoperative | |
Secondary | Histology analysis | All specimens were evaluated by two experienced pathologists blind to the groups of the patients. The macroscopic and histologic diagnosis were made based on Paris classification and Vienna classification, respectively. | 3-5days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03425032 -
Low-dose Whole Body Computed Tomography Scanning
|
||
Completed |
NCT03812185 -
TEE Image Quality Improvement With Our Devised Probe Cover
|
N/A | |
Recruiting |
NCT02519920 -
Lower Fluorescein Sodium Dose on Confocal Laser Endoscopy Image Quality and Yellow Discoloration of the Skin
|
Phase 2 |